专利检索 ap:("BIOMARIN PHARMACEUTICAL INC.") AND inv:"Adam Shaywitz" 第 1 页

1.

发明授权
Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof 有权

公开(公告)号：US11345904B2

公开(公告)日：2022-05-31

申请号：US16078546

申请日：2017-02-24

申请人： BIOMARIN PHARMACEUTICAL INC.

发明人： Saeed Moshashaee , Jason K. Pinkstaff , Adam Shaywitz , Natalie Ciaccio

IPC分类号： C12N9/26 , C12N9/24 , A61K47/65 , A61P25/28 , A61K9/00 , A61K38/43 , A61K47/26

摘要： The present disclosure relates in general to therapeutic lysosomal enzyme fusion proteins useful for treating lysosomal storage diseases, liquid formulations comprising such fusion proteins and associated methods useful for treating lysosomal storage diseases in mammals.